NMPA Approval

Compound Sulfadiazine Tablets

Approval Number

国药准字H50020389

Company重庆申高生化制药股份有限公司

Registration Date

September 25, 2020

Previous Approval Numbers

国药准字H50020389

Drug Information

Generic Name

复方磺胺嘧啶片

Dosage Form

片剂

Strength

磺胺嘧啶0.4g,甲氧苄啶50mg

Drug Type

化学药品

Registration Date

September 25, 2020

Company Information

Applicant Company

Company Name重庆申高生化制药股份有限公司

Company Address

重庆市万州区申明工业园区

Manufacturing Company

Company Name重庆申高生化制药股份有限公司

Company Address

重庆市万州区申明工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

复方磺胺嘧啶片 - NMPA 批准文号 | MedPath